Skip to content

JOHNSON & JOHNSON MEDICAL

Active Public limited companyfounded 1984active for 42 yearsLeonardo da Vincilaan 15, 1831 Machelen (Brab.)KBO/BCE: BE 0425.967.580 subsidiary of .#4 employer in Machelen, Wholesale and retail trade sector
Part of the group 13 companies in 6 countries

Lifetime

18 annual accounts with figures on one time axis, 42 filings since 1985
peak of €452.7m in 2018
€330.0m▲ 0.1%
peak of €12.2m in 2015
€10.2m▲ 9.0%
peak of €81.5m in 2021
€80.2m▲ 14.6%
€136.5m▲ 12.4%
peak of 309.6 FTE in 2015
267.5 FTE▲ 3.2%
Board29 names since 2004all names
4 directors and 3 others
Owners4 names in the annual accounts
consolidates
Documentsfilings and deeds
06-07-202625 days before the deadline
2025financial year
Powers of attorney granted to , and 32 others 15-12Powers of attorney granted to , and 13 others 27-08Equity from €69.9m to €80.2mInvestments €2.6m

Key points

from the 2025 annual accounts

Equity

€80.2m ▲ 14.6%

JOHNSON & JOHNSON MEDICAL has made a profit in every financial year since 2007.

Investments

€38,020 0.1 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Payment terms

145 days to suppliers
Suppliers
137 to 145
Customers
103 to 124

JOHNSON & JOHNSON MEDICAL pays its suppliers 8 days later than in 2024. Customers pay 21 days later.

Filings

41 annual accounts 42 filings since 1985
AprilJune31 JulyOctober1990200020102020

The 2017 accounts came 57 days late. The other nine of the last ten were filed on time.

Board

2 joined · 1 left

Board changed. Latest change 26-06-2026 · 4 in office.

Position in the sector

€10.2m

Higher net result than 95% of companies in wholesale trade. Sector median €270,502 · 3,728 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 527 companies had the same profile as JOHNSON & JOHNSON MEDICAL has now. Each dot stands for 2 companies, two years later.

96.2%
were still trading
3.0%
stopped another way
0.8%
went bankrupt
  • Large
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet
Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 527 companies, not a prediction for JOHNSON & JOHNSON MEDICAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Managing director
Managing director
Managing director
Director
  • consolidatesannual accounts 2025
  • 0.01%score equity €11.68bn (2025) · annual accounts 2025 of

Shares in 1 company,

Board & ownership

Recent changes

1 director appointed, 2 reappointments, 1 statutory auditor reappointed appointed · , and (statutory auditor) reappointed · acts as permanent representative · General meeting of 26-06-2026 · Gazette deed
New managing director appointed, resigned · Director discharge: · Board meeting of 02-02-2026 · Gazette deed
resigns as director appointed as director · General meeting of 27-01-2026 · Gazette deed
(managing director) and (managing director) resign Board meeting of 19-11-2024 · Gazette deed
All 104 events

Comparable companies

same main activity, similar in size and age
Company
JOHNSON & JOHNSON MEDICAL Machelen (Brab.) €330.0m 3.7% 35.5% 267.5
NOVARTIS PHARMA Machelen (Brab.) €378.6m 4.0% 19.0% 207.8
SANOFI BELGIUM Machelen (Brab.) €296.7m 4.8% 39.9% 185.5
SIEMENS HEALTHCARE Dilbeek €454.7m 3.6% 26.1% 294.4
Terumo BCT Europe Zaventem €369.5m 6.1% 87.4% 271
ANSELL HEALTHCARE EUROPE Anderlecht €472.7m 4.0% 23.4% 209.5
EG Brussels €263.2m 15.1% 54.0% 162
-10%0%10%20%€500m€1bn€2bn€5bn€10bn€20bnJOHNSON & JOHNSON MEDICALEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as JOHNSON & JOHNSON MEDICAL: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €109m and €590m, founded between 1973 and 1998.

Official details

Source: KBO
Status
Active since 07-06-1984Normal situation
Registered office
14 active companies are registered at this address2 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460and 1 other
Joint committees
100Auxiliary committee for blue-collar workers
200Auxiliary committee for white-collar workers · annual accounts 2022
Establishment units
2.025.017.9261831 Machelen (Brab.), registered on 27-07-1999
2.222.364.8222340 Beerse, since 01-01-2013and 4 others
Financial year end
31 December
Peppol
Reachable since 16-03-2020
Company details

Annual accounts 2025

€225.6m▲ 13.3%
Employeeson 31-12-2025
274▲ 4.6%
Filing
Filed on 06-07-2026, 25 days before the end of the filing period
Financials

Insights on JOHNSON & JOHNSON MEDICAL

JOHNSON & JOHNSON MEDICAL has existed since 1984. In 2017 turnover rose from €183.5m to €429.4m.

In February 2026, the Official Gazette published the appointment of as managing director.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about JOHNSON & JOHNSON MEDICAL

What is the company number of JOHNSON & JOHNSON MEDICAL?
The company number of JOHNSON & JOHNSON MEDICAL is 0425.967.580. The VAT number is the same number with BE in front: BE 0425.967.580.
Where is JOHNSON & JOHNSON MEDICAL based?
The registered office is at Leonardo da Vincilaan 15, 1831 Machelen (Brab.).Company details
What does JOHNSON & JOHNSON MEDICAL do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of JOHNSON & JOHNSON MEDICAL?
JOHNSON & JOHNSON MEDICAL is a public limited company (NV).
When was JOHNSON & JOHNSON MEDICAL founded?
JOHNSON & JOHNSON MEDICAL was founded on 07-06-1984.
Is JOHNSON & JOHNSON MEDICAL still active?
Yes, JOHNSON & JOHNSON MEDICAL is an active enterprise in the KBO register.
How many employees does JOHNSON & JOHNSON MEDICAL have?
JOHNSON & JOHNSON MEDICAL had an average of 267.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does JOHNSON & JOHNSON MEDICAL fall under?
In its 2022 annual accounts, JOHNSON & JOHNSON MEDICAL states joint committees 100 (Auxiliary committee for blue-collar workers) and 200 (Auxiliary committee for white-collar workers).
What is the turnover of JOHNSON & JOHNSON MEDICAL?
The turnover of JOHNSON & JOHNSON MEDICAL was €330.0m in financial year 2025, according to the filed annual accounts.
Is JOHNSON & JOHNSON MEDICAL profitable?
In financial year 2025, JOHNSON & JOHNSON MEDICAL made a profit of €10.2m.
Where can I find the annual accounts of JOHNSON & JOHNSON MEDICAL?
JOHNSON & JOHNSON MEDICAL filed 42 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of JOHNSON & JOHNSON MEDICAL due?
JOHNSON & JOHNSON MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.